This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove Blood Clot Remove Defibrillator Remove Pediatrics
article thumbnail

2024’s Mid-Year Review: FDA-Approved Cardiorenal Metabolic Drugs and Devices 

Cardiometabolic Health Congress

JULY 17, 2024

The label includes a “black box” warning for CV risk due to blood clots. Praluent (alirocumab) (Approved: 03/11/2024) Extended to pediatric patients aged 8+ with heterozygous familial hypercholesterolemia (HeFH). Join us as we examine the landmark approvals that are revolutionizing patient outcomes.

Tricuspid 59
Tricuspid Open-Heart Surgery Kidney Disease Pediatrics 59
article thumbnail

Teen Topics – The Top 10 Things to Remember About CHD as an Adult

Conquering CHD

MARCH 7, 2024

The current list of medications, especially blood thinners and rhythm drugs If your child is on Coumadin to prevent a blood clot, this is incredibly important information. For the most part, pediatric cardiologists already do an excellent job with this type of counseling.

Congenital Heart Disease 98
Congenital Heart Disease Congenital Pediatrics Heart Disease 98
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join thousands of Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024